Psychosis in Alzheimer disease—mechanisms, genetics and therapeutic opportunities

Z Ismail, B Creese, D Aarsland, HC Kales… - Nature Reviews …, 2022 - nature.com
Psychosis is a common and distressing symptom in people with Alzheimer disease, and few
safe and effective treatments are available. However, new approaches to symptom …

Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges

J Han, V Chitu, ER Stanley, ZK Wszolek… - Cellular and Molecular …, 2022 - Springer
Microglia are specialized dynamic immune cells in the central nervous system (CNS) that
plays a crucial role in brain homeostasis and in disease states. Persistent …

Cell-type-specific CAG repeat expansions and toxicity of mutant Huntingtin in human striatum and cerebellum

K Mätlik, M Baffuto, L Kus, AL Deshmukh, DA Davis… - Nature …, 2024 - nature.com
Brain region-specific degeneration and somatic expansions of the mutant Huntingtin (mHTT)
CAG tract are key features of Huntington's disease (HD). However, the relationships among …

Timing and impact of psychiatric, cognitive, and motor abnormalities in Huntington disease

B McAllister, JF Gusella, GB Landwehrmeyer, JM Lee… - Neurology, 2021 - AAN Enterprises
Objective To assess the prevalence, timing, and functional impact of psychiatric, cognitive,
and motor abnormalities in Huntington disease (HD) gene carriers, we analyzed …

What is the pathogenic CAG expansion length in Huntington's disease?

J Donaldson, S Powell, N Rickards… - Journal of …, 2021 - content.iospress.com
Abstract Huntington's disease (HD)(OMIM 143100) is caused by an expanded CAG repeat
tract in the HTT gene. The inherited CAG length is known to expand further in somatic and …

[HTML][HTML] Interleukin-6 as a marker of Huntington's disease progression: systematic review and Meta-analysis

S Eide, M Misztal, ZP Feng - Brain, Behavior, & Immunity-Health, 2023 - Elsevier
Huntington's disease (HD) is a rare, inherited disorder with a broad spectrum of
manifestations that vary with disease severity and progression. Although genetic testing can …

Brain-derived neurotrophic factor dysregulation as an essential pathological feature in Huntington's disease: mechanisms and potential therapeutics

A Speidell, N Bin Abid, H Yano - Biomedicines, 2023 - mdpi.com
Brain-derived neurotrophic factor (BDNF) is a major neurotrophin whose loss or interruption
is well established to have numerous intersections with the pathogenesis of progressive …

Longitudinal analysis of neuropsychiatric symptoms in a large cohort of early-moderate manifest Huntington's disease patients

J Ruiz-Idiago, E Pomarol-Clotet, R Salvador - Parkinsonism & Related …, 2023 - Elsevier
Background The relationship between neuropsychiatric symptoms (NPS) and other clinical
dimensions in Huntington's disease (HD) is controversial. This longitudinal study analyzed …

Low-level brain somatic mutations are implicated in schizophrenia

MH Kim, IB Kim, J Lee, SM Park, JH Kim, R Kim… - Biological …, 2021 - Elsevier
Background Somatic mutations arising from the brain have recently emerged as significant
contributors to neurodevelopmental disorders, including childhood intractable epilepsy and …

The pathobiology of depression in Huntington's disease: an unresolved puzzle

KA Jellinger - Journal of Neural Transmission, 2024 - Springer
Huntington's disease (HD) is an autosomal-dominant progressive neurodegenerative
disease that manifests with a triad of symptoms including motor dysfunctions, cognitive …